
|Videos|September 24, 2021
Dr. McVary discusses individualizing care in men with BPH
Author(s)Urology Times staff
“[BPH treatment] has to be individualized to the motivations of the patient, and also what I call his "phenotype.” How big is his prostate? How bad is this problem? And what is his tolerance for side effects?” says Kevin T. McVary, MD.
Advertisement
In this video, Kevin McVary, MD, FACS, discusses his patient selection process for BPH clinical trials and the importance of individualized care. McVary is a professor of urology and director of the Center for Male Health at Loyola University Medical Center, Maywood, Illinois.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Practical tips for AE management with the gemcitabine intravesical system
2
Team-based AE protocols improve consistency with the gemcitabine intravesical therapy system
3
Study to assess adaptive-dosed 177Lu-DOTA-HYNIC-panPSMA in mHSPC
4
First-in-human bladder transplant demonstrates sustained function at 6 months
5











